These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8440323)

  • 1. Definition of the roles for iron and essential fatty acids in cell cycle progression of normal human T lymphocytes.
    Terada N; Or R; Szepesi A; Lucas JJ; Gelfand EW
    Exp Cell Res; 1993 Feb; 204(2):260-7. PubMed ID: 8440323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of synthesis of p34cdc2 and its homologues and their relationship to p110Rb phosphorylation during cell cycle progression of normal human T cells.
    Lucas JJ; Terada N; Szepesi A; Gelfand EW
    J Immunol; 1992 Mar; 148(6):1804-11. PubMed ID: 1541821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of the tumor suppressor molecules, retinoblastoma susceptibility gene product (Rb) and p53, during cell cycle progression of normal human T cells.
    Terada N; Lucas JJ; Gelfand EW
    J Immunol; 1991 Jul; 147(2):698-704. PubMed ID: 1906503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycle.
    Terada N; Lucas JJ; Szepesi A; Franklin RA; Domenico J; Gelfand EW
    J Cell Physiol; 1993 Jan; 154(1):7-15. PubMed ID: 8419408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the murine homologue of the cell cycle control protein p34cdc2 in T lymphocytes.
    Kim YH; Proust JJ; Buchholz MJ; Chrest FJ; Nordin AA
    J Immunol; 1992 Jul; 149(1):17-23. PubMed ID: 1637418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of cell cycle entry and progression in mitogen-stimulated human B lymphocytes.
    Takase K; Terada N; Lucas JJ; Gelfand EW
    J Cell Physiol; 1995 Feb; 162(2):246-55. PubMed ID: 7529768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signals involved in T cell activation. II. Distinct roles of intact accessory cells, phorbol esters, and interleukin 1 in activation and cell cycle progression of resting T lymphocytes.
    Davis L; Lipsky PE
    J Immunol; 1986 May; 136(10):3588-96. PubMed ID: 3486215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells.
    Ling YH; el-Naggar AK; Priebe W; Perez-Soler R
    Mol Pharmacol; 1996 May; 49(5):832-41. PubMed ID: 8622633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations.
    Delia D; Goi K; Mizutani S; Yamada T; Aiello A; Fontanella E; Lamorte G; Iwata S; Ishioka C; Krajewski S; Reed JC; Pierotti MA
    Oncogene; 1997 May; 14(18):2137-47. PubMed ID: 9174049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell cycle-dependent inhibition of p34cdc2 synthesis by transforming growth factor beta 1 in cycling epithelial cells.
    Eblen ST; Fautsch MP; Burnette RJ; Joshi P; Leof EB
    Cell Growth Differ; 1994 Feb; 5(2):109-16. PubMed ID: 8180123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of cdc2 in senescent human and hamster cells.
    Richter KH; Afshari CA; Annab LA; Burkhart BA; Owen RD; Boyd J; Barrett JC
    Cancer Res; 1991 Nov; 51(21):6010-3. PubMed ID: 1933864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapamycin inhibits ribosomal protein synthesis and induces G1 prolongation in mitogen-activated T lymphocytes.
    Terada N; Takase K; Papst P; Nairn AC; Gelfand EW
    J Immunol; 1995 Oct; 155(7):3418-26. PubMed ID: 7561036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells.
    Chen HW; Huang HC
    Br J Pharmacol; 1998 Jul; 124(6):1029-40. PubMed ID: 9720770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential fatty acids and iron are involved at distinct stages of the proliferative cycle but not in the activation of human T cells.
    Or R; Kovar J; Domenico J; Gelfand EW
    Clin Immunol Immunopathol; 1992 Mar; 62(3):314-20. PubMed ID: 1371729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycle progression out of G1 sensitizes primary-cultured nontransformed T cells to TCR-mediated apoptosis.
    Radvanyi LG; Shi Y; Mills GB; Miller RG
    Cell Immunol; 1996 Jun; 170(2):260-73. PubMed ID: 8660826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
    Arita Y; Buffolino P; Coppock DL
    Exp Cell Res; 1998 Aug; 242(2):381-90. PubMed ID: 9683525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of c-fos and c-jun proteins and AP-1 binding activity during cell cycle progression of HL60 cells and phytohemagglutinin-stimulated lymphocytes.
    Tay DL; Hoffbrand AV; Wickremasinghe GR
    Exp Hematol; 1996 Feb; 24(2):277-84. PubMed ID: 8641353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new molecular role for iron in regulation of cell cycling and differentiation of HL-60 human leukemia cells: iron is required for transcription of p21(WAF1/CIP1) in cells induced by phorbol myristate acetate.
    Gazitt Y; Reddy SV; Alcantara O; Yang J; Boldt DH
    J Cell Physiol; 2001 Apr; 187(1):124-35. PubMed ID: 11241357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lovastatin inhibits G1/S transition of normal human B-lymphocytes independent of apoptosis.
    Naderi S; Blomhoff R; Myklebust J; Smeland EB; Erikstein B; Norum KR; Blomhoff HK
    Exp Cell Res; 1999 Oct; 252(1):144-53. PubMed ID: 10502407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation of p34cdc2 complex formation from phosphorylation and histone H1 kinase activity.
    Eblen ST; Fautsch MP; Burnette RJ; Snyder M; Leof EB
    Cancer Res; 1995 May; 55(9):1994-2000. PubMed ID: 7728771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.